カテゴリー： 世界, 医療/バイオ, LP Information

世界のプロポフォール&シプロフォール注射市場予測 2023年-2029年

【英語タイトル】Global Propofol and Ciprofol Injections Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11312）・商品コード：LP23DC11312
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：102
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のプロポフォール&シプロフォール注射市場」は、過去の販売実績から2022年の世界のプロポフォール&シプロフォール注射の総販売量を検討し、2023年から2029年の予測されるプロポフォール&シプロフォール注射の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のプロポフォール&シプロフォール注射の市場規模を掲載し、XXX百万米ドル規模の世界のプロポフォール&シプロフォール注射市場の詳細な分析を提供します。本インサイトレポートは、世界のプロポフォール&シプロフォール注射業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のプロポフォール&シプロフォール注射市場における各社の独自のポジションをより深く理解するために、プロポフォール&シプロフォール注射製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のプロポフォール&シプロフォール注射市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。プロポフォール&シプロフォール注射の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。プロポフォール&シプロフォール注射の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。プロポフォール&シプロフォール注射のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

プロポフォール&シプロフォール注射の世界主要メーカーとしては、Bachem、 Curia、 SI Group、 Neuland Laboratories、 Harman Finochem、 Midas Pharma、 Guangdong Jiabo Pharmaceutical、 Sichuan Biokin Pharmaceutical、 Xi’an Libang Pharmaceutical、 Beijing Sciecure Pharmaceutical、 Jiangsu Nhwa Pharmaceutical、 Haisco Pharmaceutical Groupなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のプロポフォール&シプロフォール注射市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではプロポフォール&シプロフォール注射市場をセグメンテーションし、種類別 (プロポフォール注射液、シプロフォール注射液)、用途別 (胃内視鏡検査、手術麻酔、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：プロポフォール注射液、シプロフォール注射液

・用途別区分：胃内視鏡検査、手術麻酔、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のプロポフォール&シプロフォール注射市場の10年間の市場状況・展望は？
・世界および地域別に見たプロポフォール&シプロフォール注射市場成長の要因は何か？
・プロポフォール&シプロフォール注射の市場機会はエンドマーケットの規模によってどのように変化するのか？
・プロポフォール&シプロフォール注射のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：プロポフォール&シプロフォール注射の年間販売量2018-2029、地域別現状・将来分析
・プロポフォール&シプロフォール注射の種類別セグメント：プロポフォール注射液、シプロフォール注射液
・プロポフォール&シプロフォール注射の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・プロポフォール&シプロフォール注射の用途別セグメント：胃内視鏡検査、手術麻酔、その他
・プロポフォール&シプロフォール注射の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のプロポフォール&シプロフォール注射市場
・企業別のグローバルプロポフォール&シプロフォール注射市場データ：2018-2023年の年間販売量、市場シェア
・企業別のプロポフォール&シプロフォール注射の年間売上：2018-2023年の売上、市場シェア
・企業別のプロポフォール&シプロフォール注射販売価格
・主要企業のプロポフォール&シプロフォール注射生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

プロポフォール&シプロフォール注射の地域別レビュー
・地域別のプロポフォール&シプロフォール注射市場規模2018-2023：年間販売量、売上
・主要国別のプロポフォール&シプロフォール注射市場規模2018-2023：年間販売量、売上
・南北アメリカのプロポフォール&シプロフォール注射販売の成長
・アジア太平洋のプロポフォール&シプロフォール注射販売の成長
・ヨーロッパのプロポフォール&シプロフォール注射販売の成長
・中東・アフリカのプロポフォール&シプロフォール注射販売の成長

南北アメリカ市場
・南北アメリカの国別のプロポフォール&シプロフォール注射販売量、売上（2018-2023）
・南北アメリカのプロポフォール&シプロフォール注射の種類別販売量
・南北アメリカのプロポフォール&シプロフォール注射の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のプロポフォール&シプロフォール注射販売量、売上（2018-2023）
・アジア太平洋のプロポフォール&シプロフォール注射の種類別販売量
・アジア太平洋のプロポフォール&シプロフォール注射の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のプロポフォール&シプロフォール注射販売量、売上（2018-2023）
・ヨーロッパのプロポフォール&シプロフォール注射の種類別販売量
・ヨーロッパのプロポフォール&シプロフォール注射の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のプロポフォール&シプロフォール注射販売量、売上（2018-2023）
・中東・アフリカのプロポフォール&シプロフォール注射の種類別販売量
・中東・アフリカのプロポフォール&シプロフォール注射の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・プロポフォール&シプロフォール注射の製造コスト構造分析
・プロポフォール&シプロフォール注射の製造プロセス分析
・プロポフォール&シプロフォール注射の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・プロポフォール&シプロフォール注射の主要なグローバル販売業者
・プロポフォール&シプロフォール注射の主要なグローバル顧客

地域別のプロポフォール&シプロフォール注射市場予測レビュー
・地域別のプロポフォール&シプロフォール注射市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・プロポフォール&シプロフォール注射の種類別市場規模予測
・プロポフォール&シプロフォール注射の用途別市場規模予測

主要企業分析
Bachem、 Curia、 SI Group、 Neuland Laboratories、 Harman Finochem、 Midas Pharma、 Guangdong Jiabo Pharmaceutical、 Sichuan Biokin Pharmaceutical、 Xi’an Libang Pharmaceutical、 Beijing Sciecure Pharmaceutical、 Jiangsu Nhwa Pharmaceutical、 Haisco Pharmaceutical Group
・企業情報
・プロポフォール&シプロフォール注射製品
・プロポフォール&シプロフォール注射販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Propofol and Ciprofol Injections market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Propofol and Ciprofol Injections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Propofol and Ciprofol Injections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Propofol and Ciprofol Injections is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Propofol and Ciprofol Injections players cover Bachem, Curia, SI Group, Neuland Laboratories, Harman Finochem, Midas Pharma, Guangdong Jiabo Pharmaceutical, Sichuan Biokin Pharmaceutical and Xi’an Libang Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Propofol and Ciprofol Injections Industry Forecast” looks at past sales and reviews total world Propofol and Ciprofol Injections sales in 2022, providing a comprehensive analysis by region and market sector of projected Propofol and Ciprofol Injections sales for 2023 through 2029. With Propofol and Ciprofol Injections sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Propofol and Ciprofol Injections industry.
This Insight Report provides a comprehensive analysis of the global Propofol and Ciprofol Injections landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Propofol and Ciprofol Injections portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Propofol and Ciprofol Injections market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Propofol and Ciprofol Injections and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Propofol and Ciprofol Injections.
This report presents a comprehensive overview, market shares, and growth opportunities of Propofol and Ciprofol Injections market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Propofol Injections
Ciprofol Injections
Segmentation by application
Gastrointestinal Endoscopy
Anesthesia for Surgery
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Haisco Pharmaceutical Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Propofol and Ciprofol Injections market?
What factors are driving Propofol and Ciprofol Injections market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Propofol and Ciprofol Injections market opportunities vary by end market size?
How does Propofol and Ciprofol Injections break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Propofol and Ciprofol Injections Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Propofol and Ciprofol Injections by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Propofol and Ciprofol Injections by Country/Region, 2018, 2022 & 2029
2.2 Propofol and Ciprofol Injections Segment by Type
2.2.1 Propofol Injections
2.2.2 Ciprofol Injections
2.3 Propofol and Ciprofol Injections Sales by Type
2.3.1 Global Propofol and Ciprofol Injections Sales Market Share by Type (2018-2023)
2.3.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Type (2018-2023)
2.3.3 Global Propofol and Ciprofol Injections Sale Price by Type (2018-2023)
2.4 Propofol and Ciprofol Injections Segment by Application
2.4.1 Gastrointestinal Endoscopy
2.4.2 Anesthesia for Surgery
2.4.3 Other
2.5 Propofol and Ciprofol Injections Sales by Application
2.5.1 Global Propofol and Ciprofol Injections Sale Market Share by Application (2018-2023)
2.5.2 Global Propofol and Ciprofol Injections Revenue and Market Share by Application (2018-2023)
2.5.3 Global Propofol and Ciprofol Injections Sale Price by Application (2018-2023)
3 Global Propofol and Ciprofol Injections by Company
3.1 Global Propofol and Ciprofol Injections Breakdown Data by Company
3.1.1 Global Propofol and Ciprofol Injections Annual Sales by Company (2018-2023)
3.1.2 Global Propofol and Ciprofol Injections Sales Market Share by Company (2018-2023)
3.2 Global Propofol and Ciprofol Injections Annual Revenue by Company (2018-2023)
3.2.1 Global Propofol and Ciprofol Injections Revenue by Company (2018-2023)
3.2.2 Global Propofol and Ciprofol Injections Revenue Market Share by Company (2018-2023)
3.3 Global Propofol and Ciprofol Injections Sale Price by Company
3.4 Key Manufacturers Propofol and Ciprofol Injections Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Propofol and Ciprofol Injections Product Location Distribution
3.4.2 Players Propofol and Ciprofol Injections Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Propofol and Ciprofol Injections by Geographic Region
4.1 World Historic Propofol and Ciprofol Injections Market Size by Geographic Region (2018-2023)
4.1.1 Global Propofol and Ciprofol Injections Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Propofol and Ciprofol Injections Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Propofol and Ciprofol Injections Market Size by Country/Region (2018-2023)
4.2.1 Global Propofol and Ciprofol Injections Annual Sales by Country/Region (2018-2023)
4.2.2 Global Propofol and Ciprofol Injections Annual Revenue by Country/Region (2018-2023)
4.3 Americas Propofol and Ciprofol Injections Sales Growth
4.4 APAC Propofol and Ciprofol Injections Sales Growth
4.5 Europe Propofol and Ciprofol Injections Sales Growth
4.6 Middle East & Africa Propofol and Ciprofol Injections Sales Growth
5 Americas
5.1 Americas Propofol and Ciprofol Injections Sales by Country
5.1.1 Americas Propofol and Ciprofol Injections Sales by Country (2018-2023)
5.1.2 Americas Propofol and Ciprofol Injections Revenue by Country (2018-2023)
5.2 Americas Propofol and Ciprofol Injections Sales by Type
5.3 Americas Propofol and Ciprofol Injections Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Propofol and Ciprofol Injections Sales by Region
6.1.1 APAC Propofol and Ciprofol Injections Sales by Region (2018-2023)
6.1.2 APAC Propofol and Ciprofol Injections Revenue by Region (2018-2023)
6.2 APAC Propofol and Ciprofol Injections Sales by Type
6.3 APAC Propofol and Ciprofol Injections Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Propofol and Ciprofol Injections by Country
7.1.1 Europe Propofol and Ciprofol Injections Sales by Country (2018-2023)
7.1.2 Europe Propofol and Ciprofol Injections Revenue by Country (2018-2023)
7.2 Europe Propofol and Ciprofol Injections Sales by Type
7.3 Europe Propofol and Ciprofol Injections Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Propofol and Ciprofol Injections by Country
8.1.1 Middle East & Africa Propofol and Ciprofol Injections Sales by Country (2018-2023)
8.1.2 Middle East & Africa Propofol and Ciprofol Injections Revenue by Country (2018-2023)
8.2 Middle East & Africa Propofol and Ciprofol Injections Sales by Type
8.3 Middle East & Africa Propofol and Ciprofol Injections Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Propofol and Ciprofol Injections
10.3 Manufacturing Process Analysis of Propofol and Ciprofol Injections
10.4 Industry Chain Structure of Propofol and Ciprofol Injections
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Propofol and Ciprofol Injections Distributors
11.3 Propofol and Ciprofol Injections Customer
12 World Forecast Review for Propofol and Ciprofol Injections by Geographic Region
12.1 Global Propofol and Ciprofol Injections Market Size Forecast by Region
12.1.1 Global Propofol and Ciprofol Injections Forecast by Region (2024-2029)
12.1.2 Global Propofol and Ciprofol Injections Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Propofol and Ciprofol Injections Forecast by Type
12.7 Global Propofol and Ciprofol Injections Forecast by Application
13 Key Players Analysis
13.1 Bachem
13.1.1 Bachem Company Information
13.1.2 Bachem Propofol and Ciprofol Injections Product Portfolios and Specifications
13.1.3 Bachem Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bachem Main Business Overview
13.1.5 Bachem Latest Developments
13.2 Curia
13.2.1 Curia Company Information
13.2.2 Curia Propofol and Ciprofol Injections Product Portfolios and Specifications
13.2.3 Curia Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Curia Main Business Overview
13.2.5 Curia Latest Developments
13.3 SI Group
13.3.1 SI Group Company Information
13.3.2 SI Group Propofol and Ciprofol Injections Product Portfolios and Specifications
13.3.3 SI Group Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 SI Group Main Business Overview
13.3.5 SI Group Latest Developments
13.4 Neuland Laboratories
13.4.1 Neuland Laboratories Company Information
13.4.2 Neuland Laboratories Propofol and Ciprofol Injections Product Portfolios and Specifications
13.4.3 Neuland Laboratories Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Neuland Laboratories Main Business Overview
13.4.5 Neuland Laboratories Latest Developments
13.5 Harman Finochem
13.5.1 Harman Finochem Company Information
13.5.2 Harman Finochem Propofol and Ciprofol Injections Product Portfolios and Specifications
13.5.3 Harman Finochem Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Harman Finochem Main Business Overview
13.5.5 Harman Finochem Latest Developments
13.6 Midas Pharma
13.6.1 Midas Pharma Company Information
13.6.2 Midas Pharma Propofol and Ciprofol Injections Product Portfolios and Specifications
13.6.3 Midas Pharma Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Midas Pharma Main Business Overview
13.6.5 Midas Pharma Latest Developments
13.7 Guangdong Jiabo Pharmaceutical
13.7.1 Guangdong Jiabo Pharmaceutical Company Information
13.7.2 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.7.3 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Guangdong Jiabo Pharmaceutical Main Business Overview
13.7.5 Guangdong Jiabo Pharmaceutical Latest Developments
13.8 Sichuan Biokin Pharmaceutical
13.8.1 Sichuan Biokin Pharmaceutical Company Information
13.8.2 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.8.3 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sichuan Biokin Pharmaceutical Main Business Overview
13.8.5 Sichuan Biokin Pharmaceutical Latest Developments
13.9 Xi’an Libang Pharmaceutical
13.9.1 Xi’an Libang Pharmaceutical Company Information
13.9.2 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.9.3 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Xi’an Libang Pharmaceutical Main Business Overview
13.9.5 Xi’an Libang Pharmaceutical Latest Developments
13.10 Beijing Sciecure Pharmaceutical
13.10.1 Beijing Sciecure Pharmaceutical Company Information
13.10.2 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.10.3 Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Beijing Sciecure Pharmaceutical Main Business Overview
13.10.5 Beijing Sciecure Pharmaceutical Latest Developments
13.11 Jiangsu Nhwa Pharmaceutical
13.11.1 Jiangsu Nhwa Pharmaceutical Company Information
13.11.2 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
13.11.3 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.11.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.12 Haisco Pharmaceutical Group
13.12.1 Haisco Pharmaceutical Group Company Information
13.12.2 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolios and Specifications
13.12.3 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Haisco Pharmaceutical Group Main Business Overview
13.12.5 Haisco Pharmaceutical Group Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Propofol and Ciprofol Injections Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Propofol and Ciprofol Injections Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Propofol Injections
Table 4. Major Players of Ciprofol Injections
Table 5. Global Propofol and Ciprofol Injections Sales by Type (2018-2023) & (K Units)
Table 6. Global Propofol and Ciprofol Injections Sales Market Share by Type (2018-2023)
Table 7. Global Propofol and Ciprofol Injections Revenue by Type (2018-2023) & ($ million)
Table 8. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2018-2023)
Table 9. Global Propofol and Ciprofol Injections Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Propofol and Ciprofol Injections Sales by Application (2018-2023) & (K Units)
Table 11. Global Propofol and Ciprofol Injections Sales Market Share by Application (2018-2023)
Table 12. Global Propofol and Ciprofol Injections Revenue by Application (2018-2023)
Table 13. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2018-2023)
Table 14. Global Propofol and Ciprofol Injections Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Propofol and Ciprofol Injections Sales by Company (2018-2023) & (K Units)
Table 16. Global Propofol and Ciprofol Injections Sales Market Share by Company (2018-2023)
Table 17. Global Propofol and Ciprofol Injections Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Propofol and Ciprofol Injections Revenue Market Share by Company (2018-2023)
Table 19. Global Propofol and Ciprofol Injections Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Propofol and Ciprofol Injections Producing Area Distribution and Sales Area
Table 21. Players Propofol and Ciprofol Injections Products Offered
Table 22. Propofol and Ciprofol Injections Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Propofol and Ciprofol Injections Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Propofol and Ciprofol Injections Sales Market Share Geographic Region (2018-2023)
Table 27. Global Propofol and Ciprofol Injections Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Propofol and Ciprofol Injections Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Propofol and Ciprofol Injections Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Propofol and Ciprofol Injections Sales Market Share by Country/Region (2018-2023)
Table 31. Global Propofol and Ciprofol Injections Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Propofol and Ciprofol Injections Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Propofol and Ciprofol Injections Sales by Country (2018-2023) & (K Units)
Table 34. Americas Propofol and Ciprofol Injections Sales Market Share by Country (2018-2023)
Table 35. Americas Propofol and Ciprofol Injections Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Propofol and Ciprofol Injections Revenue Market Share by Country (2018-2023)
Table 37. Americas Propofol and Ciprofol Injections Sales by Type (2018-2023) & (K Units)
Table 38. Americas Propofol and Ciprofol Injections Sales by Application (2018-2023) & (K Units)
Table 39. APAC Propofol and Ciprofol Injections Sales by Region (2018-2023) & (K Units)
Table 40. APAC Propofol and Ciprofol Injections Sales Market Share by Region (2018-2023)
Table 41. APAC Propofol and Ciprofol Injections Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Propofol and Ciprofol Injections Revenue Market Share by Region (2018-2023)
Table 43. APAC Propofol and Ciprofol Injections Sales by Type (2018-2023) & (K Units)
Table 44. APAC Propofol and Ciprofol Injections Sales by Application (2018-2023) & (K Units)
Table 45. Europe Propofol and Ciprofol Injections Sales by Country (2018-2023) & (K Units)
Table 46. Europe Propofol and Ciprofol Injections Sales Market Share by Country (2018-2023)
Table 47. Europe Propofol and Ciprofol Injections Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Propofol and Ciprofol Injections Revenue Market Share by Country (2018-2023)
Table 49. Europe Propofol and Ciprofol Injections Sales by Type (2018-2023) & (K Units)
Table 50. Europe Propofol and Ciprofol Injections Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Propofol and Ciprofol Injections Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Propofol and Ciprofol Injections Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Propofol and Ciprofol Injections Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Propofol and Ciprofol Injections Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Propofol and Ciprofol Injections Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Propofol and Ciprofol Injections
Table 58. Key Market Challenges & Risks of Propofol and Ciprofol Injections
Table 59. Key Industry Trends of Propofol and Ciprofol Injections
Table 60. Propofol and Ciprofol Injections Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Propofol and Ciprofol Injections Distributors List
Table 63. Propofol and Ciprofol Injections Customer List
Table 64. Global Propofol and Ciprofol Injections Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Propofol and Ciprofol Injections Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Propofol and Ciprofol Injections Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Propofol and Ciprofol Injections Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Propofol and Ciprofol Injections Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Propofol and Ciprofol Injections Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Propofol and Ciprofol Injections Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Propofol and Ciprofol Injections Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Propofol and Ciprofol Injections Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Propofol and Ciprofol Injections Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Propofol and Ciprofol Injections Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Propofol and Ciprofol Injections Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Propofol and Ciprofol Injections Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Propofol and Ciprofol Injections Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Bachem Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 79. Bachem Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 80. Bachem Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Bachem Main Business
Table 82. Bachem Latest Developments
Table 83. Curia Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 84. Curia Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 85. Curia Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Curia Main Business
Table 87. Curia Latest Developments
Table 88. SI Group Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 89. SI Group Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 90. SI Group Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. SI Group Main Business
Table 92. SI Group Latest Developments
Table 93. Neuland Laboratories Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 94. Neuland Laboratories Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 95. Neuland Laboratories Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Neuland Laboratories Main Business
Table 97. Neuland Laboratories Latest Developments
Table 98. Harman Finochem Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 99. Harman Finochem Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 100. Harman Finochem Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Harman Finochem Main Business
Table 102. Harman Finochem Latest Developments
Table 103. Midas Pharma Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 104. Midas Pharma Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 105. Midas Pharma Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Midas Pharma Main Business
Table 107. Midas Pharma Latest Developments
Table 108. Guangdong Jiabo Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 110. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Guangdong Jiabo Pharmaceutical Main Business
Table 112. Guangdong Jiabo Pharmaceutical Latest Developments
Table 113. Sichuan Biokin Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 114. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 115. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Sichuan Biokin Pharmaceutical Main Business
Table 117. Sichuan Biokin Pharmaceutical Latest Developments
Table 118. Xi’an Libang Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 119. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 120. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Xi’an Libang Pharmaceutical Main Business
Table 122. Xi’an Libang Pharmaceutical Latest Developments
Table 123. Beijing Sciecure Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 124. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 125. Beijing Sciecure Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Beijing Sciecure Pharmaceutical Main Business
Table 127. Beijing Sciecure Pharmaceutical Latest Developments
Table 128. Jiangsu Nhwa Pharmaceutical Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 129. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 130. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Jiangsu Nhwa Pharmaceutical Main Business
Table 132. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 133. Haisco Pharmaceutical Group Basic Information, Propofol and Ciprofol Injections Manufacturing Base, Sales Area and Its Competitors
Table 134. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolios and Specifications
Table 135. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Haisco Pharmaceutical Group Main Business
Table 137. Haisco Pharmaceutical Group Latest Developments
List of Figures
Figure 1. Picture of Propofol and Ciprofol Injections
Figure 2. Propofol and Ciprofol Injections Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Propofol and Ciprofol Injections Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Propofol and Ciprofol Injections Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Propofol and Ciprofol Injections Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Propofol Injections
Figure 10. Product Picture of Ciprofol Injections
Figure 11. Global Propofol and Ciprofol Injections Sales Market Share by Type in 2022
Figure 12. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2018-2023)
Figure 13. Propofol and Ciprofol Injections Consumed in Gastrointestinal Endoscopy
Figure 14. Global Propofol and Ciprofol Injections Market: Gastrointestinal Endoscopy (2018-2023) & (K Units)
Figure 15. Propofol and Ciprofol Injections Consumed in Anesthesia for Surgery
Figure 16. Global Propofol and Ciprofol Injections Market: Anesthesia for Surgery (2018-2023) & (K Units)
Figure 17. Propofol and Ciprofol Injections Consumed in Other
Figure 18. Global Propofol and Ciprofol Injections Market: Other (2018-2023) & (K Units)
Figure 19. Global Propofol and Ciprofol Injections Sales Market Share by Application (2022)
Figure 20. Global Propofol and Ciprofol Injections Revenue Market Share by Application in 2022
Figure 21. Propofol and Ciprofol Injections Sales Market by Company in 2022 (K Units)
Figure 22. Global Propofol and Ciprofol Injections Sales Market Share by Company in 2022
Figure 23. Propofol and Ciprofol Injections Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Propofol and Ciprofol Injections Revenue Market Share by Company in 2022
Figure 25. Global Propofol and Ciprofol Injections Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Propofol and Ciprofol Injections Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Propofol and Ciprofol Injections Sales 2018-2023 (K Units)
Figure 28. Americas Propofol and Ciprofol Injections Revenue 2018-2023 ($ Millions)
Figure 29. APAC Propofol and Ciprofol Injections Sales 2018-2023 (K Units)
Figure 30. APAC Propofol and Ciprofol Injections Revenue 2018-2023 ($ Millions)
Figure 31. Europe Propofol and Ciprofol Injections Sales 2018-2023 (K Units)
Figure 32. Europe Propofol and Ciprofol Injections Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Propofol and Ciprofol Injections Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Propofol and Ciprofol Injections Revenue 2018-2023 ($ Millions)
Figure 35. Americas Propofol and Ciprofol Injections Sales Market Share by Country in 2022
Figure 36. Americas Propofol and Ciprofol Injections Revenue Market Share by Country in 2022
Figure 37. Americas Propofol and Ciprofol Injections Sales Market Share by Type (2018-2023)
Figure 38. Americas Propofol and Ciprofol Injections Sales Market Share by Application (2018-2023)
Figure 39. United States Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Propofol and Ciprofol Injections Sales Market Share by Region in 2022
Figure 44. APAC Propofol and Ciprofol Injections Revenue Market Share by Regions in 2022
Figure 45. APAC Propofol and Ciprofol Injections Sales Market Share by Type (2018-2023)
Figure 46. APAC Propofol and Ciprofol Injections Sales Market Share by Application (2018-2023)
Figure 47. China Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Propofol and Ciprofol Injections Sales Market Share by Country in 2022
Figure 55. Europe Propofol and Ciprofol Injections Revenue Market Share by Country in 2022
Figure 56. Europe Propofol and Ciprofol Injections Sales Market Share by Type (2018-2023)
Figure 57. Europe Propofol and Ciprofol Injections Sales Market Share by Application (2018-2023)
Figure 58. Germany Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Propofol and Ciprofol Injections Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Propofol and Ciprofol Injections Sales Market Share by Application (2018-2023)
Figure 67. Egypt Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Propofol and Ciprofol Injections Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Propofol and Ciprofol Injections in 2022
Figure 73. Manufacturing Process Analysis of Propofol and Ciprofol Injections
Figure 74. Industry Chain Structure of Propofol and Ciprofol Injections
Figure 75. Channels of Distribution
Figure 76. Global Propofol and Ciprofol Injections Sales Market Forecast by Region (2024-2029)
Figure 77. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Propofol and Ciprofol Injections Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Propofol and Ciprofol Injections Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Propofol and Ciprofol Injections Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のプロポフォール&シプロフォール注射市場予測 2023年-2029年] (コード：LP23DC11312)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のプロポフォール&シプロフォール注射市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の医薬品用インドブフェン市場予測 2023年-2029年
  • 世界の医薬品用ベンズブロマロン市場予測 2023年-2029年
  • 世界のアルテミシン酸市場予測 2023年-2029年
  • 世界のアルテミシン酸市場予測 2023年-2029年
  • 世界の医薬品用カベルゴリン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆